Company registration number 10939908 (England and Wales)
LONDON MEDICAL HEALTH LIMITED
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
PAGES FOR FILING WITH REGISTRAR
LONDON MEDICAL HEALTH LIMITED
COMPANY INFORMATION
Director
Mr G K Kwei
Company number
10939908
Registered office
Accountants
Xeinadin South East Limited
Create Business Hub
5 Rayleigh Road
Shenfield
Essex
England
CM13 1AB
LONDON MEDICAL HEALTH LIMITED
CONTENTS
Page
Director's report
1
Accountants' report
2
Profit and loss account
3
Balance sheet
4
Notes to the financial statements
5 - 7
LONDON MEDICAL HEALTH LIMITED
DIRECTOR'S REPORT
FOR THE YEAR ENDED 31 AUGUST 2025
- 1 -

The director presents his annual report and financial statements for the year ended 31 August 2025.

Director

The director who held office during the year and up to the date of signature of the financial statements was as follows:

Mr G K Kwei
Small companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
Mr G K Kwei
Director
21 November 2025
LONDON MEDICAL HEALTH LIMITED
REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY ACCOUNTS OF LONDON MEDICAL HEALTH LIMITED
- 2 -

These financial statements have been prepared in accordance with our terms of engagement and in order to assist you to fulfil your duties under the Companies Acts that relate to preparing the financial statements of the company for the year ended 31 August 2025.

We have prepared these financial statements based on the accounting records, information and explanations provided by you. We do not express any opinion on the financial statements.

On the balance sheet, you have acknowledged your duties under the prevailing Companies Acts to ensure that the company keeps adequate accounting records and prepares financial statements that give a true and fair view.

You have determined that the company is exempt from the statutory requirement for an audit for this accounting year. Therefore, the financial statements are unaudited.

The financial statements are provided exclusively to the director for the limited purpose mentioned above, and may not be used or relied upon for any other purpose or by any other person, and we shall not be liable for any other usage or reliance.

Xeinadin South East Limited
Create Business Hub
5 Rayleigh Road
Shenfield
Essex
CM13 1AB
England
21 November 2025
LONDON MEDICAL HEALTH LIMITED
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 AUGUST 2025
- 3 -
2025
2024
£
£
Turnover
307,740
274,907
Cost of sales
(116,745)
(118,085)
Gross profit
190,995
156,822
Administrative expenses
(160,862)
(143,420)
Other operating income
19
-
0
Operating profit
30,152
13,402
Interest receivable and similar income
4,490
-
0
Profit before taxation
34,642
13,402
Tax on profit
(6,748)
(2,474)
Profit for the financial year
27,894
10,928

The profit and loss account has been prepared on the basis that all operations are continuing operations.

LONDON MEDICAL HEALTH LIMITED
BALANCE SHEET
AS AT 31 AUGUST 2025
31 August 2025
- 4 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
2,624
3,498
Current assets
Debtors
4
41,662
1,667
Cash at bank and in hand
118,468
146,286
160,130
147,953
Creditors: amounts falling due within one year
5
(13,701)
(5,292)
Net current assets
146,429
142,661
Net assets
149,053
146,159
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
148,953
146,059
Total equity
149,053
146,159

For the financial year ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 21 November 2025
Mr G K Kwei
Director
Company registration number 10939908 (England and Wales)
LONDON MEDICAL HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
- 5 -
1
Accounting policies
Company information

London Medical Health Limited is a private company, limited by shares, registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

The company recognises revenue from the following major sources:

- Sale of services

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

1.3
Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings
25% on reducing balance
Computers
25% on reducing balance
1.4
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

LONDON MEDICAL HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 6 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
1
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 September 2024 and 31 August 2025
14,786
Depreciation and impairment
At 1 September 2024
11,288
Depreciation charged in the year
874
At 31 August 2025
12,162
Carrying amount
At 31 August 2025
2,624
At 31 August 2024
3,498
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Other debtors
41,662
1,667
LONDON MEDICAL HEALTH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 7 -
5
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
6,748
2,474
Other taxation and social security
4,453
318
Other creditors
2,500
2,500
13,701
5,292
2025-08-31 2024-09-01 false false false 21 November 2025 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mr G K Kwei 10939908 2024-09-01 2025-08-31 10939908 bus:Director1 2024-09-01 2025-08-31 10939908 2025-08-31 10939908 2023-09-01 2024-08-31 10939908 2024-08-31 10939908 core:OtherPropertyPlantEquipment 2025-08-31 10939908 core:OtherPropertyPlantEquipment 2024-08-31 10939908 core:WithinOneYear 2025-08-31 10939908 core:WithinOneYear 2024-08-31 10939908 core:CurrentFinancialInstruments 2025-08-31 10939908 core:CurrentFinancialInstruments 2024-08-31 10939908 core:ShareCapital 2025-08-31 10939908 core:ShareCapital 2024-08-31 10939908 core:RetainedEarningsAccumulatedLosses 2025-08-31 10939908 core:RetainedEarningsAccumulatedLosses 2024-08-31 10939908 core:FurnitureFittings 2024-09-01 2025-08-31 10939908 core:ComputerEquipment 2024-09-01 2025-08-31 10939908 core:OtherPropertyPlantEquipment 2024-08-31 10939908 core:OtherPropertyPlantEquipment 2024-09-01 2025-08-31 10939908 core:CurrentFinancialInstruments core:WithinOneYear 2025-08-31 10939908 core:CurrentFinancialInstruments core:WithinOneYear 2024-08-31 10939908 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 10939908 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 10939908 bus:FRS102 2024-09-01 2025-08-31 10939908 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 10939908 bus:FullAccounts 2024-09-01 2025-08-31 xbrli:pure xbrli:shares iso4217:GBP